Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-11-04
1994-05-03
Fan, Jane T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546270, A61K 3144, C07D41312
Patent
active
053088549
ABSTRACT:
Novel aminopyridones inhibit HIV reverse transcriptase, and are useful in the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, anti-infectives, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
REFERENCES:
patent: 3654291 (1972-04-01), Witzel
patent: 3721676 (1973-03-01), Witzel
patent: 3846553 (1974-11-01), Shen
patent: 3853896 (1974-12-01), Pessolano
patent: 3853897 (1974-12-01), Witzel
patent: 4255428 (1981-03-01), Brown
patent: 4461901 (1984-07-01), Potoski
patent: 4839371 (1989-06-01), Kouse et al.
Zeffren et al. The Study of Enzyme Mechanism 1974 p. 87.
Wade Jr. Organic Chemistry 1987 Prentice-Hall Inc. p. 349.
Debyser, Z. et al. Proc. Natl. Acad. Sci, 88, 1451 (1991).
Ratner, L. et al., "Complete Nucleotide Sequence of the AIDS Virus, HTLV-III," Nature 313, 278 (1985).
Toh, H. et al., "Close Structural Resemblance . . . ," EMBO J 4, 1267 (1985).
Power, M. D. et al., "Nucleotide Sequence of SRV-1 . . . ," Science 231, 1567 (1986).
Pearl, L. H. et al., "A Structural Model of Retroviral Proteases," Nature 329, 351 (1987).
Brownstein, S. K., "Reaction of Nitroacetamide with Hypobromite," J. Org. Chem. 23, 113 (1958).
Okafor, C. O. et al.,". . . Analogues of . . . 2,3,6-Triazaphenothiazine . . . ," J. Heterocyclic Chem. 20, 199 (1983) (Okafor I).
Okafor, C. O., ". . . New Chemistry of Azaphenothiazine . . . ," J. Org. Chem. 47, 592 (1982) (Okafor II).
Paine, J. B.,". . . Synthesis of Nicotinate Esters . . . ," J. Heterocyclic Chem. 24, 351 (1987).
Baldwin, J. J. et al., "Synthesis of . . . 2-Halonicotinic Acid Derivatives," J. Org. Chem. 43, 2529 (1978).
Fauci, A. S., "Current issues in developing a strategy for dealing with AIDS," Proc. Natl. Acad. Sci. 83, 9278 (1986).
Baum, et al., "AIDS Vaccine . . .,"C&EN, pp. 7-14 (Jul. 16, 1990).
Sandstrom, E., "Antiviral Therapy," Drugs 38(3), 417(1989) (Sandstrom I).
Sandstrom, E. G. et al., "Antiviral Therapy in AIDS . . .," Drugs 34, 372 (1987) (Sandstrom II).
CA 115: 126401t, p. 24 (Sep. 30, 1991).
Waldholz, M., "Glaxo . . . Begins . . . Testing of AIDS Drug . . . ," The Wall Street Journal, p. B4 (Jul. 30, 1991).
Goldman, M. E. et al., "Pyridinone derivatives: Specific HIV-1 reverse transcriptase inhibitors . . . ," Proc. Natl. Acad. Sci. 88, 6863(1991).
Hoffman, Jr. Jacob M.
Rooney Clarence S.
Saari Walfred S.
Wai John S.
Fan Jane T.
Merck & Co. , Inc.
Meredith Roy D.
Tribble Jack L.
LandOfFree
Inhibitors of HIV reverse transcriptase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of HIV reverse transcriptase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of HIV reverse transcriptase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2115270